跳至主要内容
临床试验/NL-OMON41267
NL-OMON41267已完成3 期

Feasibility and accuracy of the Olympus Extra Wide Angle View colonoscope for the detection of colorectal lesions in comparison with the Exera III study - Feasibility of Olympus Extra Wide Angle View colonoscope

Academisch Medisch Centrum0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age greater than or equal to 18 years
  • - High risk for colorectal cancer: FOBT positive, personal or familial (first degree relatives) history of colorectal cancer or colorectal adenoma, patients with symptoms suggestive of colorectal neoplasm: rectal bleeding, recent change in frequency and consistency of stools.
  • - Status 1 and 2 of the ASA classification (fit for colonoscopy)
  • - Signed informed consent

排除标准

  • - Mental or physical condition that can adversely affect the preparation or conduct of the examination or which precludes compliance with the study and / or device instructions.
  • - Inability to undergo bowel cleansing for colonoscopy.
  • - Prior abdominal surgery of the gastrointestinal tract (other than uncomplicated appendectomy or cholecystectomy).
  • - Known or suspicion of inflammatory bowel disease.
  • - Known large (> 2 cm) colorectal polyp for polypectomy
  • - Colonic diverticulosis complication within 3 months prior inclusion.
  • - Very high risk for colorectal cancer, history of extensive polyposis, patients with known genetic disease (Familial Adenomatous Polyposis (FAP), Hereditary Non-Polyposis Colorectal Cancer (HNPCC)).
  • - Coagulation abnormalities or taking drugs affecting coagulation.
  • - Life threatening conditions
  • - Status > 2 of the ASA classification (see Appendix I).
  • - Renal insufficiency or any contraindication or medication contraindicating the administration of bowel cleansing.
  • - Female patients who are pregnant or nursing, or of childbearing potential and are not using adequate contraception.
  • - Participation in another clinical trial within 30 days prior to the Screening Visit or during this study.

研究者

相似试验